Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment

OBJECTIVE: To compare 2‐year effectiveness and discontinuation of natalizumab (NTZ) versus fingolimod (FTY) and dimethyl fumarate (DMF) in the treatment of multiple sclerosis (MS). METHODS: Patients prescribed NTZ, FTY, or DMF at the Rocky Mountain MS Center at University of Colorado were identified...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Clin Transl Neurol
Main Authors: Vollmer, Brandi L., Nair, Kavita V., Sillau, Stefan, Corboy, John R., Vollmer, Timothy, Alvarez, Enrique
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Research Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389745/
https://ncbi.nlm.nih.gov/pubmed/30847358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.700
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker